• Publications
  • Influence
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
The objective was to update previous evidence‐based medicine reviews of treatments for motor symptoms of Parkinson's disease published between 2002 and 2005. Level I (randomized, controlled trial)Expand
  • 371
  • 38
  • PDF
Overview of the extranigral aspects of Parkinson disease.
In recent years, there has been increasing recognition of the features of Parkinson disease that are not related to nigrostriatal dopamine deficiency. This review addresses selected clinical,Expand
  • 156
  • 5
  • PDF
Impulse Control and Related Disorders in Parkinson's Disease
In the past decade, impulse control disorders, punding, and dopamine dysregulation syndrome (which we refer to collectively as disinhibitory psychopathologies) have been increasingly recognized inExpand
  • 69
  • 4
The nonmotor symptoms of Parkinson's disease—An overview
Nonmotor symptoms (NMS) are very common in Parkinson's disease (PD) and may result in significant disability. The increased focus on these important clinical features represents a major advance inExpand
  • 118
  • 3
Development of marked striatal hand with antiparkinsonian medication withdrawal during traditional (Ayurvedic) medicine treatment for Parkinson s disease.
Ayurveda is a traditional medical system used widely in India and increasingly worldwide. Here, we report on a patient with Parkinson’s disease (PD) who developed marked striatal hand withExpand
  • 1
  • PDF
064 Parkinson’s disease and the gastrointestinal microbiome: clinicopathological correlations and controversies
Introduction There has been a recent surge in interest around the gastrointestinal microbiome (GM) and its association with Parkinson’s disease (PD). The GM mediates interactions between the brainExpand
082 The gastrointestinal microbiome in parkinson’s disease: impacts of motor and non-motor features, medications, lifestyle and diet
Introduction The human gastrointestinal microbiome (GM) has been proposed to be integral in the pathogenesis of Parkinson’s disease (PD). Evidence supports a bidirectional interaction between theExpand
  • 1
Adapting to post-COVID19 research in Parkinson's disease: Lessons from a multinational experience
Highlights • COVID-19 has significant impact on PD research and education activities.• Country-specific restrictions may pose challenges to PD research and require careful adaptations.• NeurologicalExpand